Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy

Hepatocellular carcinoma (HCC) is one of the deadliest cancer types worldwide. HCC is often diagnosed at a late stage when the therapeutic options are very limited. However, even at the earlier stages, the best treatment is liver transplantation, surgical resection or ablation. Surgical resection an...

Full description

Bibliographic Details
Main Authors: Panagiota Maravelia, Daniela Nascimento Silva, Giulia Rovesti, Michael Chrobok, Per Stål, Yong-Chen Lu, Anna Pasetto
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
hepatocellular carcinoma (HCC)
immunotherapies
liquid biopsy
circulating tumor DNA (ctDNA)
circulating tumor cells (CTC)
Online Access:https://www.mdpi.com/2072-6694/13/17/4334

Internet

https://www.mdpi.com/2072-6694/13/17/4334

Similar Items